SCHEMBL887929

SCHEMBL887929

OCCC/C=C/CCCCCO

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.40
HSD17B10 Q99714 2/20 0.40
ALDH1A1 P00352 1/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
TSHR P16473 1/20 0.40
CNR1 P21554 1/20 0.36
FAAH O00519 2/20 0.36
TRPV1 Q8NER1 1/20 0.36
GMNN O75496 1/20 0.36
USP2 O75604 1/20 0.36
CYP1A2 P05177 1/20 0.36
POLB P06746 1/20 0.36
MAPT P10636 1/20 0.36
CYP2C9 P11712 1/20 0.36
ALOX15 P16050 1/20 0.36
APEX1 P27695 1/20 0.36
CYP2C19 P33261 1/20 0.36
RECQL P46063 1/20 0.36
BLM P54132 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11288862 0.97 LMNA (0.42) LMNAHSD17B10ALDH1A1MEN1KMT2A
SCHEMBL11672499 0.97 LMNA (0.42) LMNAHSD17B10ALDH1A1MEN1KMT2A
SCHEMBL5251134 0.97 LMNA (0.42) LMNAHSD17B10ALDH1A1MEN1KMT2A
SCHEMBL11672493 0.97 LMNA (0.42) LMNAHSD17B10ALDH1A1MEN1KMT2A
SCHEMBL9816485 0.97 LMNA (0.42) LMNAHSD17B10ALDH1A1MEN1KMT2A
SCHEMBL6448104 0.97 LMNA (0.42) LMNAHSD17B10ALDH1A1MEN1KMT2A
SCHEMBL2956122 0.97 LMNA (0.42) LMNAHSD17B10ALDH1A1MEN1KMT2A
SCHEMBL1207736 0.97 LMNA (0.42) LMNAHSD17B10ALDH1A1MEN1KMT2A
SCHEMBL531156 0.97 LMNA (0.42) LMNAHSD17B10ALDH1A1MEN1KMT2A
SCHEMBL5251136 0.97 LMNA (0.42) LMNAHSD17B10ALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170145499-A1 METHODS FOR INDEXING SAMPLES AND SEQUENCING MULTIPLE POLYNUCLEOTIDE TEMPLATES ILLUMINA CAMBRIDGE LIMITED (US) 2017-05-25 US disclosed
US-20120316072-A1 Methods for indexing samples and sequencing multiple polynucleotide templates ILLUMINA CAMBRIDGE LIMITED (GB) 2012-12-13 US disclosed
US-20120309634-A1 METHOD FOR PAIRWISE SEQUENCING OF TARGET POLYNUCLEOTIDES ILLUMINA CAMBRIDGE LIMITED (GB) 2012-12-06 US disclosed
US-20120208194-A1 Preparation of Templates for Nucleic Acid Sequencing ILLUMINA CAMBRIDGE LIMITED (GB) 2012-08-16 US disclosed
US-8236505-B2 Method for pairwise sequencing of target polynucleotides ILLUMINA CAMBRIDGE LIMITED (GB) 2012-08-07 US disclosed
US-20120094848-A1 Method for pairwise sequencing of target polynucleotides ILLUMINA CAMBRIDGE LIMITED (GB) 2012-04-19 US disclosed
US-8105784-B2 Method for pairwise sequencing of target polynucleotides ILLUMINA CAMBRIDGE LIMITED (GB) 2012-01-31 US disclosed
US-8053192-B2 Methods for indexing samples and sequencing multiple polynucleotide templates ILLUMINA CAMBRIDGE LTD. (GB) 2011-11-08 US disclosed
US-20110223601-A1 Method for pairwise sequencing of target polynucleotides ILLUMINA CAMBRIDGE LIMITED (GB) 2011-09-15 US disclosed
US-7960120-B2 Method for pair-wise sequencing a plurality of double stranded target polynucleotides ILLUMINA CAMBRIDGE LTD. (GB) 2011-06-14 US disclosed
US-20110014657-A1 Method for sequencing a polynucleotide template ILLUMINA CAMBRIDGE LTD. 2011-01-20 US disclosed
US-7754429-B2 Method for pair-wise sequencing a plurity of target polynucleotides ILLUMINA CAMBRIDGE LIMITED (GB) 2010-07-13 US disclosed
US-20090233802-A1 Methods for indexing samples and sequencing multiple polynucleotide templates NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2009-09-17 US disclosed
US-20090118128-A1 Preparation of templates for nucleic acid sequencing ILLUMINA CAMBRIDGE LIMITED (GB) 2009-05-07 US disclosed
US-20090088327-A1 Method for sequencing a polynucleotide template SOLEXA LIMITED (GB) 2009-04-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090118128-A1 Preparation of templates for nucleic acid sequencing RNGTT, POLRMT, POLM LMNA 211/4885HSD17B10 2198/4885ALDH1A1 3780/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.